Treatment Registry

Company

RestorLife Med

RestorLife Med publishes compounded semaglutide and compounded tirzepatide, from $56 to $99 a month. The lowest requires a 3-month plan.

Published by Treatment Registry · Latest research

  • 2 programs
  • 2 identified molecules
  • 2 readings

Read from restorlifemed.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.

Go to RestorLife Med

Visit RestorLife Med

We earn nothing from this link. It opens RestorLife Med's website without a paid referral.

What it costs

initial payment (3-month medication term), including required fees on record · ◯ $56 advertised · GLP-1 Microdose, 3 month (list $113/mo)

initial payment (3-month medication term), including required fees on record · ◯ $99 advertised · Dual GIP/GLP-1 Microdose, 3 month (list $133/mo)

Terms

States

All 50 states

Across recorded programs · Evidence: September 2026

Not yet checked: pharmacy, membership and consultation fee.

Programs

EntryProgramPer month
at its shortest term
Link
EntryTR-0489ProgramCompounded semaglutidePer month at shortest term$56
GLP-1 Microdose, 3 month (list $113/mo)
Record
EntryTR-0490ProgramCompounded tirzepatidePer month at shortest term$99
Dual GIP/GLP-1 Microdose, 3 month (list $133/mo)
Record

Notes

Pricing details, service terms and questions to confirm before enrolling.

September 2026

  1. 1. Prices are for a first-order-discounted rate shown beside a crossed-out list price (e.g. '$149 $219/mo'); both numbers were captured, with perMonth set to the actual advertised price and the list price kept in each quote. In addition to the standard-dose semaglutide/tirzepatide protocols, the site sells 'microdose' tiers of each drug at lower doses/prices, recorded as separate price entries under the same drug. The homepage names the physician as 'Licensed in all 50 states,' but that describes the physician's individual licensure, not a company-wide service-area claim — the site's own Terms of Service instead says only 'certain states' are served with no list, so states was recorded as not-found rather than all-50. RestorLife Med's telemedicine consent is issued by 'Beluga Health, P.A.' — the same Beluga Health checked separately in this batch as a B2B infrastructure vendor.

Understand the terms

Before you act

Cite this

Treatment Registry. (2026). RestorLife Med: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/restorlife-med